FDA.reportPublic FDA data

Application 022499

Type
NDA
Sponsor
TRIS PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CLONIDINECLONIDINESUSPENSION, EXTENDED RELEASE;ORALEQ 0.09MG BASE/MLNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
38766SUPPL2010-09-29
29784SUPPL2010-09-29
42538ORIG2010-05-12
24324ORIG2010-05-12
29783ORIG2009-12-11
17646ORIG2009-12-10